TELMISARTAN 80mg. IP + HYDROCHLOROTHIAZIDE 12.5mg. IP

Belongs to the class of anti-hypertensive primarily taken for the reduction of high blood pressure. Provides an effective, rational, and generally well-tolerated treatment option for the management of patients with hypertension. (Greg L Plosker, 2008) An effective and well-tolerated when used to reduce SBP and DBP in patients with mild to moderate hypertension. (J B McGill, 2001) Provides large blood pressure reductions and prevents cardiovascular events in patients at high risk. (L M Ruilope, 2012) Significantly more effective at lowering BP than valsartan 160 /hydrochlorothiazide 12.5 in overweight/obese patients with hypertension and type 2 diabetes. (Arya M Sharma, 2007) An effective and well-tolerated treatment option for patients with hypertension. (Sverre E Kjeldsen, 2010) Significantly more efficacious than telmisartan monotherapies in patients with mild to moderate hypertension. (Steen Neldam, 2014) A suitable approach for difficult-to-treat patients with moderate to severe hypertension. (Sverre E. Kjeldsen MD, 2013)